Mariakerke, Belgium

Timothy Haemers

This inventor holds 1 USPTO granted patent. Top assignee: University of Ghent. Active years: 2009.


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Timothy Haemers

Introduction

Timothy Haemers is a notable inventor based in Mariakerke, Belgium. He has made significant contributions to the field of chemistry, particularly in the development of anti-parasitic agents. His work is characterized by a focus on novel phosphonic acid compounds that have the potential to combat infectious diseases.

Latest Patents

Haemers holds a patent for "Organophosphoric derivatives useful as anti-parasitic agents." This invention relates to novel phosphonic acid compounds with a specific structural formula. The compounds feature various substituents, including fluoro, chloro, bromo, and others, making them versatile in their applications. These compounds are particularly useful as anti-infectious and anti-parasitic agents, with a focus on anti-malaria properties. He has 1 patent to his name.

Career Highlights

Timothy Haemers is affiliated with the University of Ghent, where he conducts research and develops innovative solutions in the field of chemistry. His academic background and research endeavors have positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Haemers has collaborated with notable colleagues, including Jochen Wiesner and Hassan Jomaa. These partnerships have enhanced his research capabilities and contributed to the advancement of his innovative projects.

Conclusion

Timothy Haemers exemplifies the spirit of innovation in the field of chemistry through his research and patent contributions. His work on anti-parasitic agents showcases the potential for scientific advancements to address pressing health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…